ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Co-Founder Laura Ziskin Dies of Complications From Breast Cancer at 61

June 17, 2011

DRCCA’s New Board Of Scientific Counselors to Meet Sept. 18-19

August 22, 1980

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

In Brief: Thomas Jordan Promoted At Bristol-Myers, Markison To Succeed Him In Oncology Div.

February 28, 1992